PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 23, 2026Pacing and Clinical Electrophysiology0 citations

Dual‐Chamber Leadless Pacemaker Implants in the Young

View Full Paper
AMAkshitha MamidiDCDaniel Cortez

Key Points

  • To assess the feasibility and outcomes of dual-chamber leadless pacemakers in young patients under 21 years.
  • Implanted dual-chamber leadless pacemakers in five young patients at UC Davis Medical Center.
  • Preferred implantation approach was the internal jugular vein, with one case using femoral access after lead extraction.
  • Monitored atrial and ventricular parameters post-implantation.
  • Five patients received the AVEIR DR dual-chamber leadless pacemaker, median age 15 years.
  • Median predicted atrial and ventricular longevity were 11.8 and 14.6 years, respectively.
  • No complications were reported during a median follow-up of 13 months.

Abstract

Abstract Introduction Young populations with traditional dual‐chamber pacemakers are prone to re‐intervention compared to their adult populations due to their active lifestyle. AVEIR DR Dual‐Chamber Leadless Pacemakers are a new and less invasive approach to traditional pacemakers. Currently, few reports exist to support dual‐chamber leadless pacemaker implants in the young. Methods AVEIR DR dual‐chamber leadless pacemakers were implanted in young patients (< 21 years old), at UC Davis Medical Center. Internal jugular vein was the preferred approach for most patients during implantation; however, one patient had a femoral approach after lead extraction. Results Five patients received the AVEIR DR dual‐chamber leadless pacemaker with a median age of 15 years, and a median weight of 65.8 kg. Access from the internal jugular vein was used in four out of five patients. Median predicted atrial longevity and ventricular longevity were 11.8 and 14.6 years, respectively. Atrial and ventricular impedance, threshold, and pacing were monitored with no complications with a median follow‐up of 13 months. Conclusion Dual‐chamber leadless pacemaker implants are feasible in young patients through femoral and internal jugular vein access.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mamidi et al. (2026) studied this question.

synapsesocial.com/papers/69c08bcaa48f6b84677f9a8ahttps://doi.org/10.1111/pace.70085
Ask AI
Helpful
Bookmark
Share
View Full Paper